Roch doliveux bio
Roch doliveux bio and husband!
Roch doliveux bio
Oxford Biomedica Appoints Dr. Roch Doliveux as Non-Executive Chairman
Oxford, UK – 1 June, 2020: Oxford Biomedica plc (LSE:Oxford Biomedica) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, is pleased to announce that Dr.
Roch Doliveux will become Non-Executive Chairman of the Group with effect from 24 June 2020. As announced on 18 March 2020, Dr Lorenzo Tallarigo informed the Group of his intention to retire from Oxford Biomedica’s Board.
Dr Tallarigo will step down as Chairman at the Group’s AGM on 23 June 2020. Accordingly, Dr Tallarigo will no longer be standing for reappointment at the AGM and the resolution regarding his reappointment will be withdrawn.
Dr.
Doliveux is currently the Chairman of the Board of Directors at Pierre Fabre S.A and a Non-Executive Director at Stryker Corporation and UCB SA. Dr. Doliveux was previously the Chief Executive Officer of UCB SA for ten years during which time he transformed the company